1. Home
  2. IMRN vs DLPN Comparison

IMRN vs DLPN Comparison

Compare IMRN & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.89

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.38

Market Cap

17.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRN
DLPN
Founded
1994
1996
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
17.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMRN
DLPN
Price
$0.89
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
34.9K
Earning Date
02-27-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,777,422.00
$53,371,115.00
Revenue This Year
N/A
$10.62
Revenue Next Year
N/A
$13.78
P/E Ratio
N/A
N/A
Revenue Growth
48.63
3.86
52 Week Low
$0.88
$0.75
52 Week High
$2.48
$1.88

Technical Indicators

Market Signals
Indicator
IMRN
DLPN
Relative Strength Index (RSI) 25.63 30.49
Support Level $0.87 $1.41
Resistance Level $0.97 $1.65
Average True Range (ATR) 0.06 0.09
MACD -0.01 -0.02
Stochastic Oscillator 4.01 6.25

Price Performance

Historical Comparison
IMRN
DLPN

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: